Index of /wp-content/uploads/2025/03/
| Name | Last Modified | Size |
|---|---|---|
 Parent Directory | ||
![[IMG]](/wp-content/uploads/2025/03/A-Bergin-Headshot-3-1137x1536.jpg) A-Bergin-Headshot-3-1137x1536.jpg | 2025-03-10 08:49 | 207k |
![[IMG]](/wp-content/uploads/2025/03/A-Bergin-Headshot-3-150x150.jpg) A-Bergin-Headshot-3-150x150.jpg | 2025-03-10 08:49 | 6k |
![[IMG]](/wp-content/uploads/2025/03/A-Bergin-Headshot-3-222x300.jpg) A-Bergin-Headshot-3-222x300.jpg | 2025-03-10 08:49 | 13k |
![[IMG]](/wp-content/uploads/2025/03/A-Bergin-Headshot-3-758x1024.jpg) A-Bergin-Headshot-3-758x1024.jpg | 2025-03-10 08:49 | 111k |
![[IMG]](/wp-content/uploads/2025/03/A-Bergin-Headshot-3-768x1038.jpg) A-Bergin-Headshot-3-768x1038.jpg | 2025-03-10 08:49 | 114k |
![[IMG]](/wp-content/uploads/2025/03/A-Bergin-Headshot-3.jpg) A-Bergin-Headshot-3.jpg | 2025-03-10 08:49 | 242k |
![[IMG]](/wp-content/uploads/2025/03/E-Obaze-1-1229x1536.jpg) E-Obaze-1-1229x1536.jpg | 2025-03-07 10:37 | 128k |
![[IMG]](/wp-content/uploads/2025/03/E-Obaze-1-150x150.jpg) E-Obaze-1-150x150.jpg | 2025-03-07 10:37 | 5k |
![[IMG]](/wp-content/uploads/2025/03/E-Obaze-1-240x300.jpg) E-Obaze-1-240x300.jpg | 2025-03-07 10:37 | 10k |
![[IMG]](/wp-content/uploads/2025/03/E-Obaze-1-768x960.jpg) E-Obaze-1-768x960.jpg | 2025-03-07 10:37 | 56k |
![[IMG]](/wp-content/uploads/2025/03/E-Obaze-1-819x1024.jpg) E-Obaze-1-819x1024.jpg | 2025-03-07 10:37 | 63k |
![[IMG]](/wp-content/uploads/2025/03/E-Obaze-1.jpg) E-Obaze-1.jpg | 2025-03-07 10:37 | 887k |
 Icosapent-ethyl-23006-Plain-English-Summary.pdf | 2025-03-20 14:21 | 232k |
| Icosapent-ethyl-23006-Technical-Summary.pdf | 2025-03-20 14:21 | 341k |
| Mosunetuzumab-23023-Plain-English-Summary.pdf | 2025-03-24 11:15 | 149k |
| Mosunetuzumab-23023-Technical-Summary.pdf | 2025-03-24 11:15 | 297k |
| Rimegepant-plain-english-summary.docx.pdf | 2025-03-13 10:06 | 340k |
| Technical-Summary-Ivosidenib-23016-FINALupdate.pdf | 2025-06-20 08:54 | 377k |